UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 934

Sortiert nach

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

Diabetes care, 2015-10, Vol.38 (10), p.1964-1974

2015

Link zum Volltext

Verfügbarkeit prüfen

Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes

Diabetes care, 2018-10, Vol.41 (10), p.2178-2186

2018

Link zum Volltext

Verfügbarkeit prüfen

Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes

Diabetes (New York, N.Y.), 2019-09, Vol.68 (9), p.1830-1840

2019

Link zum Volltext

Verfügbarkeit prüfen

Learning From Past Failures of Oral Insulin Trials

Diabetes (New York, N.Y.), 2018-07, Vol.67 (7), p.1211-1215

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives

The journal of clinical endocrinology and metabolism, 2017-08, Vol.102 (8), p.2881-2886

2017

Link zum Volltext

Verfügbarkeit prüfen

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

The lancet. Diabetes & endocrinology, 2013-12, Vol.1 (4), p.306-316

2013

Link zum Volltext

Verfügbarkeit prüfen

Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity

JCI insight, 2019-02, Vol.4 (3)

2019

Link zum Volltext

Verfügbarkeit prüfen

Testing the NKT cell hypothesis of human IDDM pathogenesis

The Journal of clinical investigation, 2002-09, Vol.110 (6), p.793-800

2002

Link zum Volltext

Verfügbarkeit prüfen

Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation

The Journal of immunology (1950), 2011-12, Vol.187 (11), p.5921-5930

2011

Link zum Volltext

Verfügbarkeit prüfen

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

The New England journal of medicine, 2019-08, Vol.381 (7), p.603-613

2019

Link zum Volltext

Verfügbarkeit prüfen

Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes

Diabetes (New York, N.Y.), 2015-10, Vol.64 (10), p.3510-3520

2015

Link zum Volltext

Verfügbarkeit prüfen

Temporal development of T cell receptor repertoires during childhood in health and disease

JCI insight, 2022-09, Vol.7 (18)

2022

Link zum Volltext

Verfügbarkeit prüfen

Peripheral immunophenotyping of AITD subjects reveals alterations in immune cells in pediatric vs adult-onset AITD

iScience, 2022-01, Vol.25 (1), p.103626-103626, Article 103626

2022

Link zum Volltext

Verfügbarkeit prüfen

Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders

Diabetes (New York, N.Y.), 2013-11, Vol.62 (11), p.3766-3774

2013

Link zum Volltext

Verfügbarkeit prüfen

Advances in Diabetes Treatment — Once-Weekly Insulin

The New England journal of medicine, 2020-11, Vol.383 (22), p.2171-2172

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis

Diabetologia, 2019-04, Vol.62 (4), p.655-664

2019

Link zum Volltext

Verfügbarkeit prüfen

Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes

Diabetes (New York, N.Y.), 2017-03, Vol.66 (3), p.722-734

2017

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune polyglandular syndromes

Nature reviews. Endocrinology, 2010-05, Vol.6 (5), p.270

2010

Link zum Volltext

Verfügbarkeit prüfen

Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes

Diabetes care, 2014-10, Vol.37 (10), p.2746-2754

2014

Link zum Volltext

Verfügbarkeit prüfen

Medical progress: autoimmune polyendocrine syndromes

The New England journal of medicine, 2004-05, Vol.350 (20), p.2068

2004

Link zum Volltext

Verfügbarkeit prüfen

Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data

Diabetes (New York, N.Y.), 2012-08, Vol.61 (8), p.2066-2073

2012

Link zum Volltext

Verfügbarkeit prüfen

Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function

Diabetes care, 2023-10, Vol.46 (10), p.1848-1856

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 934

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(792)
Mit Volltextzugriff
(826)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(541)
Life Sciences & Biomedicine
(492)
Humans
(439)
Male
(242)
Female
(241)
Adult
(186)
Middle Aged
(154)
Biological And Medical Sciences
(133)
Medical Sciences
(122)
Adolescent
(108)
Diabetes
(101)
Child
(94)
Endocrinology & Metabolism
(86)
Aged
(78)
Young Adult
(70)
Diabetes Mellitus, Type 1 - Immunology
(67)
Cardiovascular System & Cardiology
(66)
Immunology
(65)
Cardiac & Cardiovascular Systems
(63)
Animals
(58)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes

Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes

Learning From Past Failures of Oral Insulin Trials

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity

Testing the NKT cell hypothesis of human IDDM pathogenesis

Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes

Temporal development of T cell receptor repertoires during childhood in health and disease

Peripheral immunophenotyping of AITD subjects reveals alterations in immune cells in pediatric vs adult-onset AITD

Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders

Advances in Diabetes Treatment — Once-Weekly Insulin

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis

Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes

Autoimmune polyglandular syndromes

Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes

Medical progress: autoimmune polyendocrine syndromes

Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data

Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function

Suchergebnisse filtern